Introduction: Myasthenia gravis is a chronic autoimmune neuromuscular disease, presents with weakness and fatigability of striated skeletal muscles. It is a rare disease in Cameroon. We report an uncommon case of myasthenia gravis in a patient with feeding difficulties, notion of oronasal reflux and swallowing disorders as first complaints. Observation: We report the case of a 29-year-old woman consulted at our department of Otolaryngology and Cervico-Facial Surgery for dysphagia and swallowing disorders. She also presented with facial diplegia, oculomotor paralysis, nasal voice, and dysarthria which has been evolving for several years now. The clinical examination revealed multiple cranial nerve palsies. The complementary workup showed a decrement of more than 50% in the electroneuromyography and the presence of anti-acetylcholine receptor autoantibodies in the blood workup. A diagnosis of myasthenia confirms clinical presumption. We initially observed a worsening of neuromuscular disorders despite the pyridostigmine treatment and subsequently a clear improvement of the clinical features concerning swallowing and speech disorders, oculomotricity and facial diplegia under a treatment combining prednisone and azathioprine. Conclusion: Myasthenia gravis is a rare and potentially fatal autoimmune neuromuscular disease. We thus highlight the atypical clinical presentation and therapeutic itinerary of our patient and the importance to think about this clinical diagnosis in front of any multiple cranial nerve paralysis in otolaryngology consultation.
References
[1]
Carpenter, R., MC Donald, T. and Howard, F. (1979) The Otolaryngologic Presentation of Myasthenia Gravis. The Laryngoscope, 89, 922-928. https://doi.org/10.1288/00005537-197906000-00008
[2]
Montero-Odasso, M. (2006) Dysphonia as First Symptom of Late-Onset Myasthenia Gravis. Journal of General Internal Medicine, 21, C4-C6. https://doi.org/10.1111/j.1525-1497.2006.00343.x
[3]
Elnazeir, M., Narayanan, S., Badugu, P., Hussain, A., Tareen, T., Hernandez, A.R., et al. (2020) Myasthenia Gravis Masquerading as an Idiopathic Unilateral Facial Paralysis (Bell’s Palsy)—A Very Rare and Unique Clinical Find. Frontiers in Neurology, 11, 709. https://doi.org/10.3389/fneur.2020.00709
Razafindrasata, S.R., Razafimahefa, J., Lemahafaka, G.J., Zodaly, N. and Tehindraza-narivelo, A.D. (2020) Evolution clinique de la myasthénie auto-immune en neurologie à Antananarivo, Madagascar.The Pan Afrcan Medical Journal, 37, Article No. 304. https://doi.org/10.11604/pamj.2020.37.304.18733
[6]
Midaoui, A.E., Messouak, O. and Belahsen, M. (2010) La Myasthénie. Annales de Medecine et de Therapeutique, 2, 54-65.
[7]
Balabbigari, N., Purewal, J., Sakul, N., Purewal, A., Kankanala, V., Califano, T., Cranial Nerve, I.X. and Weakness, X. (2020) An Unusual Initial Presentation of Myasthenia Gravis. American Journal of Case Reports, 21, e923750-1-e923750-4. https://doi.org/10.12659/AJCR.923750
[8]
Martinka, I., Fulova, M., Spalekova, M. and Spalek, P. (2018) Epidemiology of Myasthenia Gravis in Slovakia in the Years 1977-2015. Neuroepidemiology, 50, 153-159. https://doi.org/10.1159/000487886
[9]
Bubuioc, A.M., Kudebayeva, A., Turuspekova, S., Lisnic, V. and Leone, M.A. (2021) The Epidemiology of Myasthenia Gravis. Journal of Medicine and Life, 14, 7-16. https://doi.org/10.25122/jml-2020-0145
[10]
Owono Etoundi, P., Bengono Bengono, R., Ndikontar, R., Afane Ela, A. and Ze Minkande, J. (2016) Détresse Respiratoire Aiguë Révélant une Myasthénie. à propos d’un Cas à l’Hôpital Central de Yaoundé. Health Science and Disease, 17, 1-3.
[11]
Lompo, D.L., Some, N.é., Ouedraogo, A.M., Yonli, R.P., Diallo, O., Napon, C, et al. (2021) Profil clinique et paraclinique de la myasthénie auto-immune à Ouagadougou au Burkina Faso. Médecine Tropicale et Santé Internationale, 1, 1-12.
[12]
Matuja, W., Aris, E., Gabone, J. and Mgaya, E. (2001) Incidence and Characteristics of Myasthenia Gravis in Dar El Salaam, Tanzania. East African Medical Journal, 78，473-476. https://doi.org/10.4314/eamj.v78i9.8978
[13]
Heckmann, J.M., Hansen, P., Van Toorn, R., Lubbe, E., Van Rensburg, E.J. and Wilmshurst, J. (2012) The Characteristics of Juvenile Myasthenia Gravis among South Africans. South African Medical Journal, 102, 532-536. https://doi.org/10.7196/SAMJ.5390
[14]
Fall, M., Awbeck Fall, A., Léye, A., Ndiaye, M. and Moreira Diop, T. (2015) La myasthénie auto-immune de l’adulte lors d’une consultation décentralisée de neurologie au centre hospitalier national de Pikine dans la banlieue de Dakar-Sénégal. Revue Neurologique (Paris), 171, A153. https://doi.org/10.1016/j.neurol.2015.01.337
[15]
Heckmann, J.M., Owen, E.P. and Little, F. (2007) Myasthenia Gravis in South Africans: Racial Differences in Clinical Manifestations. Neuromuscular Disorders, 17, 929-934. https://doi.org/10.1016/j.nmd.2007.07.002
[16]
O’Hare, M. and Doughty, C. (2019) Update on Ocular Myasthenia Gravis. Seminars in Neurology, 39, 749-760. https://doi.org/10.1055/s-0039-1700527
[17]
Bourque, P.R. and Breiner, A. (2018) Myasthenia Gravis. Canadian Medical Association Journal, 190, E1141-E1141. https://doi.org/10.1503/cmaj.180656
[18]
Domenico, R., Centonze, D., Alesina, A. and Marchese-Ragona, R. (2020) Myasthenia Gravis Associated with SARS-CoV-2 Infection. Annals of Internal Medicine, 173, 1027-1028. https://doi.org/10.7326/L20-0845
[19]
Gwathmey, K. and Burns, T. (2015) Myasthenia Gravis. Seminars in Neurology, 35, 327-339. https://doi.org/10.1055/s-0035-1558975
[20]
Hendricks, T.M., Bhatti, M.T., Hodge, D.O. and Chen, J.J. (2019) Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study. American Journal of Ophthalmology, 205, 99-105. https://doi.org/10.1016/j.ajo.2019.04.017
[21]
Fortin, E., Cestari, D.M. and Weinberg, D.H. (2018) Ocular Myasthenia Gravis: An Update on Diagnosis and Treatment. Current Opinion in Ophthalmology, 29, 477-484. https://doi.org/10.1097/ICU.0000000000000526
[22]
Mandaliya, R., Kulandaivel, K., Nowotarski, N., Buddhdev, K. and Patel, R. (2015) A Challenging Diagnosis of Fluctuating Dyspnea: Myasthenia Gravis. Journal of Clinical and Diagnostic Research, 9, 6-8. https://doi.org/10.7860/JCDR/2015/12389.6015
[23]
Abudalou, M., Malkowski, M., Robles, M.R., Vega, E.A. and Slama, M.C.C. A (2021) Rare Presentation of a Rare Disease: Oropharyngeal Dysphagia as the Main Manifestation of Myasthenia Gravis. Cureus, 13, e16880. https://doi.org/10.7759/cureus.16880
[24]
Evoli, A. (2017) Rare Presentation of a Rare Disease: Oropharyngeal Dysphagia as the Main Manifestation of Myasthenia Gravis. Current Opinion in Neurobiology, 30, 464-470. https://doi.org/10.1097/WCO.0000000000000473
[25]
Rousseff, R.T. (2021) Diagnosis of Myasthenia Gravis. Journal of Clinical Medicine, 10, Article 1736. https://doi.org/10.3390/jcm10081736
[26]
Sieb, J.P. (2014) Myasthenia Gravis: An Update for the Clinician. Clinical and Experimental Immunology, 175, 408-418. https://doi.org/10.1111/cei.12217
[27]
Alhaidar, M.K., Abumurad, S., Soliven, B. and Rezania, K. (2022) Current Treatment of Myasthenia Gravis. Journal of Clinical Medicine, 11, Article 1597. https://doi.org/10.3390/jcm11061597
